As of 2026-09-29, the Intrinsic Value of Atea Pharmaceuticals Inc (AVIR) is -51.63 USD. This Atea valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.20 USD, the upside of Atea Pharmaceuticals Inc is -1,092.95%.
Based on its market price of 5.20 USD and our intrinsic valuation, Atea Pharmaceuticals Inc (AVIR) is overvalued by 1,092.95%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -51.63 - -51.63 | -51.63 | -1,092.95% |
| P/E | (36.18) - (46.51) | (54.73) | -1152.5% |
| DDM - Stable | (12.88) - (40.69) | (26.78) | -615.1% |
| DDM - Multi | (11.35) - (29.11) | (16.47) | -416.7% |
| Market Cap (mil) | 416.16 |
| Beta | 0.55 |
| Outstanding shares (mil) | 80.03 |
| Enterprise Value (mil) | 339.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.90% |
| Cost of Debt | 5.00% |
| WACC | 8.42% |